内克塔治疗(NKTR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NKTR 内克塔治疗

盘前交易 04-19 04:23:19 EDT

1.32

-0.03

-2.22%

最高1.36	最低1.27	成交量357.58万
今开1.32	昨收1.35	日振幅6.67%
总市值2.42亿	流通市值2.15亿	总股本1.84亿
成交额466.77万	换手率2.19%	流通股本1.63亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NKTR","market":"US","secType":"STK","nameCN":"内克塔治疗","latestPrice":1.32,"timestamp":1713470400000,"preClose":1.35,"halted":0,"volume":3575770,"delay":0,"floatShares":163107027,"shares":183617817,"eps":-1.452918,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.03,"latestTime":"04-19 04:23:19 EDT","open":1.32,"high":1.36,"low":1.27,"amount":4667650.678658,"amplitude":0.066667,"askPrice":1.51,"askSize":100,"bidPrice":1.17,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.452918,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713533400000},"adr":0,"adjPreClose":1.32,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":1.32,"preClose":1.32,"latestTime":"19:30 EDT","volume":1011986,"amount":1335816.73,"timestamp":1713483010521},"volumeRatio":0.6949739037819519},"requestUrl":"/m/hq/s/NKTR","defaultTab":"news","newsList":[{"id":"2428518423","title":"内克塔治疗盘中异动 早盘股价大跌5.17%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428518423","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428518423?lang=zh_cn&edition=full","pubTime":"2024-04-18 22:40","pubTimestamp":1713451241,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日22时40分，内克塔治疗股票出现异动，股价大幅下跌5.17%。截至发稿，该股报1.28美元/股，成交量69.6421万股，换手率0.38%，振幅5.19%。内克塔治疗股票所在的生物技术行业中，整体跌幅为0.21%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182240417a53ce1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182240417a53ce1c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428058342","title":"内克塔治疗盘中异动 股价大跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428058342","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428058342?lang=zh_cn&edition=full","pubTime":"2024-04-17 23:02","pubTimestamp":1713366127,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日23时02分，内克塔治疗股票出现异动，股价快速跳水5.37%。截至发稿，该股报1.41美元/股，成交量42.3884万股，换手率0.23%，振幅5.37%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.67%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172302077a537fe8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172302077a537fe8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427006154","title":"内克塔治疗盘中异动 早盘急速跳水5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427006154","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427006154?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:41","pubTimestamp":1713188487,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日21时41分，内克塔治疗股票出现波动，股价大幅跳水5.37%。截至发稿，该股报1.58美元/股，成交量25.2096万股，换手率0.14%，振幅5.39%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.93%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152141277a52da5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152141277a52da5c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426787282","title":"内克塔治疗盘中异动 急速下跌5.01%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426787282","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426787282?lang=zh_cn&edition=full","pubTime":"2024-04-12 21:31","pubTimestamp":1712928704,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日21时31分，内克塔治疗股票出现波动，股价大幅下挫5.01%。截至发稿，该股报1.50美元/股，成交量14.0425万股，换手率0.08%，振幅6.27%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。内克塔治疗股票所在的生物技术行业中，整体跌幅为0.29%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404122131457a527511&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404122131457a527511&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426525021","title":"内克塔治疗盘中异动 股价大涨13.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426525021","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426525021?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:31","pubTimestamp":1712842292,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日21时31分，内克塔治疗股票出现异动，股价急速上涨13.57%。截至发稿，该股报1.47美元/股，成交量12.0161万股，换手率0.07%，振幅8.53%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.32%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112131328767f9cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112131328767f9cb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426411587","title":"内克塔治疗盘中异动 早盘大幅跳水5.34%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426411587","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426411587?lang=zh_cn&edition=full","pubTime":"2024-04-09 22:43","pubTimestamp":1712673807,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日22时43分，内克塔治疗股票出现波动，股价急速下跌5.34%。截至发稿，该股报1.24美元/股，成交量41.7268万股，换手率0.23%，振幅6.87%。内克塔治疗股票所在的生物技术行业中，整体跌幅为0.17%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。该公司拥有肿瘤学、免疫学和病毒学研究药物的全资研发管线，以及一系列获批的合作药物。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092243277a51a81d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092243277a51a81d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425404913","title":"内克塔治疗盘中异动 早盘股价大跌6.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425404913","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425404913?lang=zh_cn&edition=full","pubTime":"2024-04-08 22:05","pubTimestamp":1712585150,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日22时05分，内克塔治疗股票出现波动，股价急速跳水6.44%。截至发稿，该股报1.24美元/股，成交量42.4987万股，换手率0.23%，振幅6.82%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。内克塔治疗股票所在的生物技术行业中，整体跌幅为0.20%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040822055187e7e8fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040822055187e7e8fc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425630562","title":"内克塔治疗盘中异动 急速上涨5.30%报1.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425630562","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425630562?lang=zh_cn&edition=full","pubTime":"2024-04-05 22:56","pubTimestamp":1712328986,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日22时56分，内克塔治疗股票出现异动，股价大幅上涨5.30%。截至发稿，该股报1.39美元/股，成交量121.17万股，换手率0.66%，振幅9.09%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.66%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040522562687e7e2d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040522562687e7e2d6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424248392","title":"内克塔治疗盘中异动 股价大涨6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424248392","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424248392?lang=zh_cn&edition=full","pubTime":"2024-04-04 21:32","pubTimestamp":1712237579,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日21时32分，内克塔治疗股票出现波动，股价大幅上涨6.54%。截至发稿，该股报1.11美元/股，成交量4.5301万股，换手率0.02%，振幅0.96%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.45%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404042132597a51065f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404042132597a51065f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424127841","title":"内克塔治疗盘中异动 急速拉升6.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424127841","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424127841?lang=zh_cn&edition=full","pubTime":"2024-04-03 21:59","pubTimestamp":1712152786,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日21时59分，内克塔治疗股票出现波动，股价快速拉升6.32%。截至发稿，该股报1.010美元/股，成交量6.787万股，换手率0.04%，振幅4.21%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.08%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040321594787e7df22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040321594787e7df22&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420517273","title":"内克塔治疗盘中异动 早盘股价大涨5.79%报0.899美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420517273","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420517273?lang=zh_cn&edition=full","pubTime":"2024-03-19 22:28","pubTimestamp":1710858506,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日22时28分，内克塔治疗股票出现异动，股价快速上涨5.79%。截至发稿，该股报0.899美元/股，成交量18.0262万股，换手率0.10%，振幅6.81%。内克塔治疗股票所在的生物技术行业中，整体跌幅为0.04%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。该公司拥有肿瘤学、免疫学和病毒学研究药物的全资研发管线，以及一系列获批的合作药物。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319222827791b7b14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319222827791b7b14&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419033639","title":"内克塔治疗盘中异动 临近午盘股价大跌5.06%报0.845美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419033639","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419033639?lang=zh_cn&edition=full","pubTime":"2024-03-13 23:46","pubTimestamp":1710344767,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日23时46分，内克塔治疗股票出现波动，股价大幅跳水5.06%。截至发稿，该股报0.845美元/股，成交量60.2592万股，换手率0.33%，振幅7.53%。内克塔治疗股票所在的生物技术行业中，整体跌幅为0.43%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。公司拥有肿瘤学、免疫学、病毒学等临床试验药物的全资研发渠道，并拥有一批获批准的合作药物。在病毒学领域，该公司相信选择性免疫调节剂可以用于治疗人类的病毒感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313234607791a1fcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313234607791a1fcf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418709311","title":"内克塔治疗盘中异动 下午盘急速下跌5.56%报0.903美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418709311","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418709311?lang=zh_cn&edition=full","pubTime":"2024-03-09 02:03","pubTimestamp":1709920982,"startTime":"0","endTime":"0","summary":"北京时间2024年03月09日02时03分，内克塔治疗股票出现异动，股价急速下跌5.56%。截至发稿，该股报0.903美元/股，成交量59.9892万股，换手率0.33%，振幅9.92%。内克塔治疗股票所在的生物技术行业中，整体跌幅为0.73%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。公司拥有肿瘤学、免疫学、病毒学等临床试验药物的全资研发渠道，并拥有一批获批准的合作药物。在病毒学领域，该公司相信选择性免疫调节剂可以用于治疗人类的病毒感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403090203027918ade6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403090203027918ade6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418061669","title":"内克塔治疗2023财年实现净利润-2.76亿美元，同比增加25.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418061669","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418061669?lang=zh_cn&edition=full","pubTime":"2024-03-09 00:22","pubTimestamp":1709914960,"startTime":"0","endTime":"0","summary":"12月31日，内克塔治疗公布财报，公告显示公司2023财年净利润为-2.76亿美元，同比增加25.00%；其中营业收入为90.12百万美元，同比减少2.11%，每股基本收益为-1.45美元。从资产负债表来看，内克塔治疗总负债2.67亿美元，其中短期债务19.26百万美元，资产负债比为1.50，流动比率为0.07。机构评级：截至2023年12月31日，当前有2家机构对内克塔治疗目标价做出预测，其中目标均价为3.00美元，其中最低目标价为1.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403090022438b18f6be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403090022438b18f6be&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417076073","title":"内克塔治疗盘中异动 快速上涨5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417076073","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417076073?lang=zh_cn&edition=full","pubTime":"2024-03-07 22:43","pubTimestamp":1709822586,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日22时43分，内克塔治疗股票出现波动，股价急速上涨5.48%。截至发稿，该股报0.960美元/股，成交量13.6926万股，换手率0.07%，振幅7.68%。内克塔治疗股票所在的生物技术行业中，整体涨幅为2.45%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。公司拥有肿瘤学、免疫学、病毒学等临床试验药物的全资研发渠道，并拥有一批获批准的合作药物。在病毒学领域，该公司相信选择性免疫调节剂可以用于治疗人类的病毒感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030722430679184724&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030722430679184724&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417971052","title":"内克塔治疗盘中异动 股价大涨5.19%报0.930美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417971052","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417971052?lang=zh_cn&edition=full","pubTime":"2024-03-06 22:33","pubTimestamp":1709735630,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日22时33分，内克塔治疗股票出现波动，股价大幅上涨5.19%。截至发稿，该股报0.930美元/股，成交量5.6431万股，换手率0.03%，振幅4.52%。内克塔治疗股票所在的生物技术行业中，整体跌幅为0.14%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。公司拥有肿瘤学、免疫学、病毒学等临床试验药物的全资研发渠道，并拥有一批获批准的合作药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030622335087e7681f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030622335087e7681f&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nektar.com","stockEarnings":[{"period":"1week","weight":-0.1646},{"period":"1month","weight":0.5204},{"period":"3month","weight":1.4682},{"period":"6month","weight":1.5576},{"period":"1year","weight":0.4116},{"period":"ytd","weight":1.3363}],"compareEarnings":[{"period":"1week","weight":-0.0357},{"period":"1month","weight":-0.0314},{"period":"3month","weight":0.0354},{"period":"6month","weight":0.186},{"period":"1year","weight":0.2062},{"period":"ytd","weight":0.0509}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nektar Therapeutics于1990年在加州成立，并于1998年重新在特拉华州注册。这是临床阶段生物制药公司，其利用PEG修饰和先进的聚合物共轭技术平台开发一个管道的候选药物。这些平台是为了认识其作用机制确保新分子实体的发展。当前专用管道包括跨多个治疗领域包括肿瘤、疼痛、抗感染和免疫领域候选药物。研究和开发活动涉及两种小分子和生物药物的候选。公司通过使用专有先进聚合物共轭技术来修改药效基因创建新的分子实体的化学结构，从而来创建创新候选药物。司收入来源于与伙伴合作协议，它可以接收合同研究支付、根据临床进展和监管进展或净销售额获得里程碑付款、版税或生产收入。","yearOnYearQuotes":[{"month":1,"riseRate":0.566667,"avgChangeRate":0.047978},{"month":2,"riseRate":0.5,"avgChangeRate":0.00268},{"month":3,"riseRate":0.4,"avgChangeRate":0.004229},{"month":4,"riseRate":0.433333,"avgChangeRate":0.001309},{"month":5,"riseRate":0.37931,"avgChangeRate":0.010886},{"month":6,"riseRate":0.4,"avgChangeRate":-0.018551},{"month":7,"riseRate":0.433333,"avgChangeRate":-0.018183},{"month":8,"riseRate":0.466667,"avgChangeRate":0.036795},{"month":9,"riseRate":0.466667,"avgChangeRate":0.014605},{"month":10,"riseRate":0.366667,"avgChangeRate":-0.026724},{"month":11,"riseRate":0.7,"avgChangeRate":0.094193},{"month":12,"riseRate":0.633333,"avgChangeRate":0.03444}],"exchange":"NASDAQ","name":"内克塔治疗","nameEN":"Nektar Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"内克塔治疗(NKTR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供内克塔治疗(NKTR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"内克塔治疗,NKTR,内克塔治疗股票,内克塔治疗股票老虎,内克塔治疗股票老虎国际,内克塔治疗行情,内克塔治疗股票行情,内克塔治疗股价,内克塔治疗股市,内克塔治疗股票价格,内克塔治疗股票交易,内克塔治疗股票购买,内克塔治疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"内克塔治疗(NKTR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供内克塔治疗(NKTR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}